Olivier Clatz
Co-founder of Therapixal
Olivier Clatz is the French co-founder of AI medical diagnosis company Therapixel, creator of MammoScreen breast cancer screening and diagnosis tool. Prior to co-founding Therapixel, Clatz worked for six years as a research scientist at INRIA (National Institute for Research in Digital Science and Technology) based at the Sophia Antipolis technology park near Antibes, in the south of France. His later work with INRIA focused on exploiting machine learning algorithms for medical imaging processing. Prior to this, he was a research associate at Harvard Medical School, in the US. In 2006, he completed his PhD at INRIA on the concept of personalized medicine. Clatz also holds a PhD in philosophy from the Ecole des Mines de Paris, and a master's degree in applied mathematics from the Ecole Normale Supérieure Paris-Saclay. Currently, he works at the French Government’s Commissariat Générale pour l’Investissement managing the national program AI For Diagnostics. He left Therapixel in 2019.
The rest of the content is only available if you are logged in.
RECOMMENDED